← Back to catalogue
Published

Glucosylceramidase beta

vr.tr.glucosylceramidase-beta · thing-q420038

Enable an agent to identify glucosylceramidase beta, assess its molecular integrity and catalytic competence, and select justified characterization or handling actions.

Thing Registry Physical world and living systems PHY.MAT

Bundle → Layer → Finding → Questions Filled

6 bundles · 11 layers · 17 findings · 33 questions

Enzyme identity Resolve which biological protein the registry name denotes.

Registry referent

Establish the intended entity and its authoritative identifiers.

Protein versus encoding gene

Human GBA1 is a gene record linked to lysosomal acid glucosylceramidase protein records; the registry must identify which entity it owns. [NCBI GBA1](https://www.ncbi.nlm.nih.gov/gene/2629)

  1. Does the originating registry record denote the enzyme protein, its encoding gene or an enzyme activity class? boundary
  2. Which original identifier and source establish that interpretation? provenance

Homolog discrimination

Separate the intended enzyme from proteins sharing its reaction.

GBA1 and GBA2 discrimination

GBA2 is a non-lysosomal glucosylceramidase with overlapping hydrolytic activity, making reaction identity insufficient for assigning GBA1. [UniProt GBA2](https://www.uniprot.org/uniprotkb/Q9HCG7/entry)

  1. Which species-qualified accession or sequence identifies the protein under examination? definition
  2. What molecular or experimental evidence excludes GBA2 and other contributing glucosidases? boundary
Molecular form Describe the particular processed, modified or engineered enzyme being assessed.

Sequence and processing

Anchor residue-level interpretation to a defined protein form.

Reference and maturation

The human reference entry includes isoforms and processing into a mature form; sequence and numbering conventions must accompany comparisons. [UniProt GBA1](https://www.uniprot.org/uniprotkb/P04062/entry)

  1. Which accession version and isoform define the reference sequence? provenance
  2. Which residues are present in the measured mature protein or recombinant construct? measurement
  3. Are reported substitutions numbered against the precursor, mature chain or another documented reference? definition

Glycoform and integrity

Characterize differences beyond the encoded amino acid sequence.

Measured protein form

Record glycosylation, intact mass, fragmentation and aggregation as preparation-specific observations rather than universal constants.

  1. What glycosylation profile and intact mass were measured for this preparation? measurement
  2. What fraction is intact protein, and what evidence detects fragments or aggregates? measurement
Catalysis and assay Connect reported activity to the substrate, reaction and measurement conditions.

Substrate and products

Define the chemical transformation being evaluated.

Glucosylceramide hydrolysis

The reference enzyme hydrolyzes glucosylceramides to glucose and ceramides; assays should identify the substrate species and measured product. [UniProt GBA1](https://www.uniprot.org/uniprotkb/P04062/entry)

  1. Which glucosylceramide molecular species or artificial substrate is supplied? definition
  2. Which product or substrate-depletion measurement demonstrates turnover? measurement
  3. What evidence supports extending an artificial-substrate result to glucosylceramide hydrolysis? boundary

Activity attribution

Make activity values comparable and distinguish enzyme signal from interference.

Conditioned specific activity

Treat activity as a conditional measurement requiring defined substrate presentation, normalization and controls.

  1. What pH, temperature, substrate concentration, lipid composition and detergent conditions produced the activity value? measurement
  2. How were background signal, other glucosidases and nonlinearity with time or enzyme amount excluded? measurement
  3. Should an incompatible assay be repeated before comparing this enzyme with another preparation? action
Lysosomal function Connect enzyme competence with delivery and substrate access in cells.

Delivery and localization

Assess whether the enzyme reaches the relevant compartment.

LIMP-2 trafficking context

LIMP-2 participates in GCase trafficking to lysosomes; localization evidence should accompany claims about cellular enzyme function. [GCase trafficking study](https://pubmed.ncbi.nlm.nih.gov/26094596/)

  1. What imaging or fractionation evidence demonstrates lysosomal localization in the studied cells? measurement
  2. Was LIMP-2 abundance or association measured when investigating altered localization? measurement

Activation and substrate access

Represent the environment supporting lipid-substrate turnover.

Saposin C context

Saposin C supports glucocerebrosidase function, and defects in this context can accompany impaired lipid degradation. [Saposin C and LIMP-2 deficiency study](https://pmc.ncbi.nlm.nih.gov/articles/PMC11204053/)

  1. Is saposin C endogenous, supplemented, deficient or unmeasured in this system? measurement
  2. How is glucosylceramide presented to the enzyme in the cellular or reconstituted membrane system? definition
  3. Which experiment would distinguish deficient enzyme catalysis from inadequate activation or substrate access? action
Preparation and use Determine whether a particular enzyme preparation supports its intended experimental use.

Preparation provenance

Trace the enzyme material and its suitability for a stated experiment.

Lot and construct evidence

Link each preparation to its source, expression system, construct, purification record and measured contaminants.

  1. Which lot, expression host, construct and purification record identify this material? provenance
  2. Could co-purifying glucosidases, residual inhibitors or formulation components alter the intended readout? boundary
  3. Which acceptance criteria must this preparation meet for the proposed biochemical or cellular experiment? action

Handling and retention

Track whether handling preserves measurable enzyme performance.

Activity after storage

Base storage and reuse decisions on preparation-specific instructions and measured retained activity.

  1. What buffer, temperature, storage duration and freeze-thaw history apply to this aliquot? provenance
  2. How much activity remains relative to a baseline measured with the same assay? measurement
  3. Does the aliquot meet the stated reuse criteria, or does it require recharacterization or replacement? action
Evidence and external alignment What the world already says about this thing, gathered so the model can be checked against it.

Reported evidence

Findings from the breadth pass, kept separate from the structural claims.

Check these first

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these check these first hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Kinds and varieties

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these kinds and varieties hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Identifiers and schemes

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these identifiers and schemes hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Standards and regulation

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these standards and regulation hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Real-world use

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these real-world use hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Failure modes and hazards

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these failure modes and hazards hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Neighbouring kinds and how to tell them apart

Recalled without web access and unsourced; every item is a lead to verify.

  1. Which of these neighbouring kinds and how to tell them apart hold for the sense of Glucosylceramidase beta this model covers, and on what evidence? provenance

Classifiers Filled

Family
Thing Registry
Category
Physical world and living systems
Entry kind
thing
Plane
PHY
Domain
PHY.MAT

What it is Filled

Glucosylceramidase beta is an enzyme that hydrolyses glucosylceramide into glucose and ceramide, usually referring to the lysosomal enzyme encoded by human GBA1.

In scope

  • Species, protein accession, sequence version and relationship to the encoding gene
  • Precursor processing, mature protein, sequence variants and glycosylation
  • Glucosylceramide hydrolysis and experimentally supported substrate specificity
  • Lysosomal localization, trafficking and activity-supporting interactions
  • Assay-specific activity, molecular integrity and preparation suitability

Out of scope

  • The GBA1 genomic locus, inheritance and transcriptional regulation as independently modeled entities
  • GBA2 and other glucosidases as separate enzyme identities
  • Glucosylceramide, ceramide and glucose as independently modeled substances
  • Gaucher disease, Parkinson's disease and patient diagnosis or prognosis
  • Therapeutic formulations, prescribing, dosing and manufacturing authorization

Why it exists Filled

Enable an agent to identify glucosylceramidase beta, assess its molecular integrity and catalytic competence, and select justified characterization or handling actions.

Distinguishing features Filled

  • Require a species-qualified protein sequence or accession: human UniProt P04062 identifies lysosomal acid glucosylceramidase associated with GBA1. [UniProt GBA1](https://www.uniprot.org/uniprotkb/P04062/entry)
  • Test hydrolysis of glucosylceramide to glucose and ceramide; activity on a generic artificial beta-glucoside alone does not establish the intended enzyme identity. [UniProt GBA1](https://www.uniprot.org/uniprotkb/P04062/entry)
  • Distinguish GBA1 from GBA2 using molecular identity and cellular localization because both can hydrolyze glucosylceramide. [UniProt GBA2](https://www.uniprot.org/uniprotkb/Q9HCG7/entry)
  • Distinguish the protein from its encoding DNA by the evidence object: protein sequence, peptides or intact protein versus a genomic or transcript accession. [NCBI GBA1](https://www.ncbi.nlm.nih.gov/gene/2629)
  • For recombinant or therapeutic material, compare construct sequence, processing and preparation identifiers before treating it as equivalent to the endogenous enzyme.

What robots and AI may and may not do Filled

Must not

  • Infer or disclose a person's genetic variants or disease risk from data without consent.
  • Advise a particular patient on enzyme replacement or other treatment.
  • Overstate research links to other diseases as established fact.
  • Present a research-grade preparation as fit for human use.

Only with a human decision

  • Any use of genetic test results about a person.
  • Releasing an enzyme preparation for clinical use.

May

  • Describe the enzyme, its reaction and its gene, citing biochemical sources.
  • Report its link to Gaucher disease and approved enzyme therapies from official sources.
  • Record the identity, activity and storage of a research enzyme preparation.

Moral aspects Filled

  • Variants in its gene affect disease risk, making genetic data about it sensitive.
  • Treatments for rare diseases are costly, raising questions of fair access.

Who is affected

  • People with Gaucher disease and families
  • Carriers of gene variants
  • Researchers

Owners Filled

Steward

Nobody owns the enzyme; holders of preparations and marketing authorization holders of therapies answer for them.

Master systems

  • Protein and gene databases
  • National medicines registers for therapeutic forms

Links to other meta-models Filled

parent

  • Q8047 - registry parent class

What else AI and robots need to interact with it Filled

Identity and identifiers required Filled

  • Vercy registry: vr.tr.glucosylceramidase-beta
  • Wikidata: Q420038 (https://www.wikidata.org/wiki/Q420038)

Direct properties required Filled

  • Species-qualified protein identity: Organism taxonomy identifier, protein accession and sequence version
  • Molecular form: Precursor, mature endogenous protein, recombinant construct or characterized variant
  • Sequence variation: Reference sequence, residue-numbering convention and explicit substitutions or deletions
  • Glycosylation profile: Site occupancy percentage and glycoform relative abundance under a named method
  • Catalytic specific activity: µmol product/min/mg enzyme, with substrate, pH, temperature and additives specified
  • Assay environment: pH, temperature in °C, substrate concentration in µM and lipid or detergent composition
  • Cellular localization: Lysosomal localization demonstrated, mislocalized, mixed localization or unmeasured
  • Interaction context: Measured association or experimental supplementation with LIMP-2, saposin C and specified membranes
  • Preparation integrity: Intact, fragmented, aggregated, mixed or uncharacterized, with method and date
  • Retained activity: Percentage of initial activity after specified storage or handling conditions

Recognition required Filled

  • Not visible; identified by sequence, activity assays and labels.
  • Research and therapeutic preparations carry different labelling.

Capabilities and actions required Filled

  • Resolve an enzyme label against species-qualified protein records and flag ambiguous mappings.
  • Compare endogenous and recombinant forms using sequence, processing and glycosylation evidence.
  • Select and interpret glucosylceramide hydrolysis assays with appropriate specificity controls.
  • Investigate reduced activity through separate measurements of abundance, localization and catalytic competence.
  • Accept, recharacterize or exclude an enzyme preparation from a stated experiment using documented quality criteria.

Hazards and failure modes required Filled

  • Loss of activity from poor storage gives false results.
  • Misinterpreted genetic findings cause needless anxiety or false reassurance.

Standards and interfaces required Filled

  • The Enzyme Commission classification maintained by the International Union of Biochemistry and Molecular Biology assigns glucosylceramidase to EC 3.2.1.45.

Context of use required Filled

  • Glucosylceramidase beta is encountered in studies of lysosomal lipid metabolism and the breakdown of glucosylceramide.
  • The human enzyme is investigated in research on Gaucher disease and biological pathways associated with Parkinson disease.
  • Purified preparations and cellular samples are used to study enzyme identity, folding, localization and catalytic activity.

Sources Filled

  1. Wikidata item Q420038: Glucosylceramidase beta - identity and sense of the item
  2. Wikipedia: Glucocerebrosidase - general description of the item

Open questions

  • Does the registry's originating identifier denote human GBA1 protein, its gene, a cross-species enzyme concept or the broader glucosylceramidase activity class?
  • Does an existing Vercy world model already own this concept, requiring a registry link instead of a second model?
  • Which orthologs, isoforms, engineered variants and therapeutic enzyme forms belong within this entry's authoritative granularity?
  • Which assay conditions and specificity controls should establish comparable activity measurements for the intended uses?
  • Which preparation-specific evidence establishes acceptable glycosylation, purity, storage conditions and retained activity?

Machine files

Provenance

thing registry research (pass 2) · unreviewed

Built from: models/things/publications/thing-q420038/spec.json